Quantum Capital Management LLC NJ lowered its stake in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 1.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 280,790 shares of the technology company’s stock after selling 5,408 shares during the quarter. Veeva Systems comprises approximately 7.3% of Quantum Capital Management LLC NJ’s investment portfolio, making the stock its 5th largest holding. Quantum Capital Management LLC NJ’s holdings in Veeva Systems were worth $62,681,000 as of its most recent SEC filing.
Other hedge funds have also recently modified their holdings of the company. Board of the Pension Protection Fund acquired a new position in shares of Veeva Systems during the fourth quarter valued at about $27,000. Raiffeisen Bank International AG acquired a new position in shares of Veeva Systems during the third quarter valued at about $28,000. Newbridge Financial Services Group Inc. increased its holdings in shares of Veeva Systems by 322.6% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 131 shares of the technology company’s stock valued at $29,000 after acquiring an additional 100 shares in the last quarter. Activest Wealth Management increased its holdings in shares of Veeva Systems by 3,175.0% during the fourth quarter. Activest Wealth Management now owns 131 shares of the technology company’s stock valued at $29,000 after acquiring an additional 127 shares in the last quarter. Finally, BOK Financial Private Wealth Inc. acquired a new position in shares of Veeva Systems during the fourth quarter valued at about $33,000. Institutional investors and hedge funds own 88.20% of the company’s stock.
Veeva Systems Stock Down 1.3%
Shares of NYSE VEEV opened at $159.44 on Friday. The business’s 50 day moving average price is $165.06 and its 200 day moving average price is $192.11. The firm has a market cap of $25.90 billion, a P/E ratio of 28.42, a P/E/G ratio of 0.69 and a beta of 0.95. Veeva Systems Inc. has a 52 week low of $148.05 and a 52 week high of $310.50.
Insider Buying and Selling
In other Veeva Systems news, Director Priscilla Hung sold 750 shares of the company’s stock in a transaction that occurred on Thursday, April 30th. The stock was sold at an average price of $155.64, for a total value of $116,730.00. Following the sale, the director owned 3,253 shares in the company, valued at approximately $506,296.92. This represents a 18.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 10.60% of the company’s stock.
Analyst Ratings Changes
Several equities analysts have recently issued reports on VEEV shares. UBS Group cut their price objective on shares of Veeva Systems from $220.00 to $190.00 and set a “neutral” rating on the stock in a report on Thursday, June 4th. Raymond James Financial reiterated an “outperform” rating and issued a $225.00 target price on shares of Veeva Systems in a research report on Thursday, June 4th. Stifel Nicolaus dropped their target price on Veeva Systems from $245.00 to $230.00 and set a “buy” rating on the stock in a research report on Thursday, June 4th. BMO Capital Markets dropped their target price on Veeva Systems from $220.00 to $175.00 and set a “market perform” rating on the stock in a research report on Thursday, June 4th. Finally, William Blair reiterated an “outperform” rating on shares of Veeva Systems in a research report on Tuesday, March 10th. Eighteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Veeva Systems currently has an average rating of “Moderate Buy” and an average price target of $250.96.
View Our Latest Analysis on Veeva Systems
Veeva Systems Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Further Reading
- Five stocks we like better than Veeva Systems
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
